Explore immune checkpoint blockade (PD-1, CTLA-4) in cancer immunotherapy with Biovista Vizit.
Tags: ABATACEPT, CANCER, CTLA4, CYTOKINE PRODUCTION, IMMUNE RESPONSE, IPILIMUMAB, LYMPHOCYTE ACTIVATION, MELANOMA, NIVOLUMAB, PD-1, PEMBROLIZUMAB, PROGRAMMED CELL DEATH, REGULATORY T-LYMPHOCYTES, T CELL ACTIVATION